CompletedNot Applicable

Nonmyeloablative Allogeneic Transplant

United States36 participantsStarted 2001-10

Plain-language summary

Allogeneic transplant from a matched sibling for the treatment of a variety of illnesses including bone marrow failure states, leukemias, myelodysplastic or myeloproliferative syndromes, lymphoma, or myeloma using a nonmyeloablative preparative regimen.

Who can participate

Age range18 Years – 72 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age \> 55 years or
✓. Age \< 55 and LVEF \< 45% or creatinine clearance \< 60 ml/min
✓. Ability to cover the cost of the transplant, necessary medications, and transportation/housing.
✓. Caregiver must be available while outpatient

Exclusion criteria

✕. Prior allogeneic stem cell or bone marrow transplant
✕. Current or past history of invasive mycotic infection
✕. Breast Feeding

What they're measuring

Engraftment

Timeframe: One year

Trial details

NCT IDNCT01272817

SponsorScripps Health

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-10

View on ClinicalTrials.gov More Aplastic Anemia trials